ARCHIVES

FDA Approves New Device For Glioblastoma Multiforme

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

January 8, 1982

Cooperative Groups: Group Affiliates, Statistical Offices At Top Of NCI’s Most Needy Cases List

November 13, 1998

NCAB Sets Bypass Budget Figures at $1.074 Billion

May 28, 1982

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern”

September 26, 2014

Funding Opportunities.

March 22, 2002